<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04873167</url>
  </required_header>
  <id_info>
    <org_study_id>U Palermo</org_study_id>
    <nct_id>NCT04873167</nct_id>
  </id_info>
  <brief_title>Effects of Adherence to a Mediterranean Diet Style on Cardiovascular Risk</brief_title>
  <official_title>Effects of Adherence to a Mediterranean Diet Style on Cardiovascular Risk by Means Its Influence on Serum Levels of Ceramides and on Some Atherothrombotic Candidate Gene Expression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Palermo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Palermo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the effect of adherence to Mediterranean Diet on some surrogate vascular&#xD;
      markers and on gene expression of some cardiometabolic genes&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators have designed a study project to evaluate in a sample of patients with high&#xD;
      cardiovascular risk:&#xD;
&#xD;
        1. The effects of adherence to Mediterranean Diet on serum levels of some metabolic&#xD;
           variables (glucose blood levels, serum LDL cholesterol, serum total cholesterol, serum&#xD;
           triglycerides)&#xD;
&#xD;
        2. The effects of adherence to Mediterranean Diet on serum levels of some ceramides and of&#xD;
           adiponectin and resistin at 6 and 12-month follow-up&#xD;
&#xD;
        3. The effects of adherence to a Mediterranean Diet style on some surrogate markers of&#xD;
           vascular damage such ad endothelial function measured by means of the evaluation of&#xD;
           reactive hyperemia index (RHI) and arterial stiffness markers (PWV, AIX) at 6 and&#xD;
           12-month follow-ups&#xD;
&#xD;
        4. The effects of adherence to Mediterranean Diet on the genetic expression of some&#xD;
           cardiometabolic and atherothrombotic candidate genes at 12-month follow-up&#xD;
&#xD;
        5. The effects of the Mediterranean diet adherence on the incidence of cardio and&#xD;
           cerebrovascular events at 12 and 18 month follow-ups considering respectively:&#xD;
&#xD;
             1. composite endpoint: myocardial infarction, ischemic stroke and death from&#xD;
                cardiovascular causes&#xD;
&#xD;
             2. secondary endpoint: myocardial infarction, stroke, death from cardiovascular causes&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects on metabolic variables</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Effects of adherence to Mediterranean Diet in determining a change in serum levels of some metabolic variables (glucose blood levels in mg/dl, serum LDL cholesterol in mg/dl, serum Total cholesterol in mg/dl, serum triglycerides in mg/dl) from baseline to 12 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effects on serum resistin serum levels</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Effects of adherence to Mediterranean Diet in determining a change from baseline serum levels of resistin in ng/ml to 6 and 12 month follow-ups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effects on serum ceramides.</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Effects of adherence to Mediterranean Diet in determining a change from baseline serum levels of some ceramides in ug/ml to 6 and 12 month follow-ups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effects on adiponectin serum levels</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Effects of adherence to Mediterranean Diet in determining a change from baseline serum levels of adiponectin in mcg/ml to 6 and 12 month follow-ups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects on surrogate cardiovascular marker (endothelial dysfunction)</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Effects of adherence to a Mediterranean Diet style in determining a change from baseline values of some surrogate markers of vascular damage such as endothelial function measured by means the evaluation of RHI (reactive hyperemia index) to 6 and 12 month follow-ups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects on arterial stiffness indexes</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Effects of adherence to a Mediterranean Diet style in determining a change from baseline values of some surrogate markers of vascular damage such as arterial stiffness markers (PWV in m/s, AIX in 100 × ((P2-P1)/(Pulse Pressure) to 6 and 12 month follow-ups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effects on gene expression</measure>
    <time_frame>Baseline and12 months</time_frame>
    <description>Effects of adherence to Mediterranean Diet in determining a change in the genetic expression of some cardiometabolic and atherothrombotic candidate genes (- C_29347861_10, rs7903146, SNP (single nucleotide polymorphism) of TCF7L2 (Transcription Factor 7 Like 2)&#xD;
C_32667060_10, rs17782313, by MC4R ( melanocortin receptor 4)&#xD;
C_30090620_10, rs9939609, SNP of FTO (Fat mass and obesity-associated protein)&#xD;
C_29347861_10, rs7903146, SNP of TCF7L2&#xD;
C_9639448_10, rs13702, SNP of LPL (lipoprotein lipase) ) at 12 month follow-up with Real-Time PCR (polymerase chain reaction assay)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects on cardiovascular events</measure>
    <time_frame>Baseline to 24 months</time_frame>
    <description>Effects of the Mediterranean diet adherence on the incidence of new cardio and cerebrovascular events at 12 and 24 months follow ups considering a composite endpoint: myocardial infarction, ischemic stroke and death from cardiovascular causes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">155</enrollment>
  <condition>Cardiovascular Risk Factor</condition>
  <arm_group>
    <arm_group_label>Low Fat Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects subjected to a low-fat dietary regime</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mediterranean Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects subjected to a mediterranean dietary regime</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>low fat</intervention_name>
    <description>subjects subjected to a low-fat dietary regime</description>
    <arm_group_label>Low Fat Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>mediterranean diet</intervention_name>
    <description>subjects subjected to a mediterranean dietary regime</description>
    <arm_group_label>Mediterranean Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  at least two of the following eligibility criteria:&#xD;
&#xD;
               1. Type 2 diabetes mellitus&#xD;
&#xD;
               2. Arterial hypertension&#xD;
&#xD;
               3. BMI ≥ 25&#xD;
&#xD;
               4. Active smoking&#xD;
&#xD;
               5. Family history of early cardiovascular disease&#xD;
&#xD;
               6. Previous cardiovascular or cerebrovascular events (&gt; 6 months)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  All patients with recent (&lt;6 months) cardiovascular or cerebrovascular events were&#xD;
             excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonino tuttolomondo</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Palermo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Palermo</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 17, 2021</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Palermo</investigator_affiliation>
    <investigator_full_name>Antonino Tuttolomondo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

